Leafbuyer Technologies, Inc. Announces Record Results: 20% Increase in Quarterly Revenue, 68% Increase in Gross Margins and 134% Increase in Net Income

February 25, 2025 11:00 PM

Leafbuyer Technologies Inc. (OTCQB:LBUY) ("Leafbuyer" or "the Company"), a leading cannabis technology and marketing platform, announced today that quarterly revenue rose 20% year over year in the quarter ending December 31, 2024. The financial data reflects the GAAP revenue booked in the quarter versus the same quarter of the previous year.Kurt Rossner, Chief Executive Officer of Leafbuyer stated, "The company had nice momentum in the last...

Read more

1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million

February 25, 2025 6:05 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its fourth quarter ("Q4 2024") and audited annual financial results for the years ended July 31, 2024 and 2023 ("Fiscal 2024"). All amounts expressed are in Canadian dollars.The Company owns 91% of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary...

Read more

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

February 25, 2025 6:00 PM

MedMira Inc. (MedMira) (TSXV:MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows MedMira to expedite its growth in the Canadian market with the recently Health Canada approved Multiplo® TP/HIV rapid antibody test and its Reveal® G4 HIV-1/2 rapid antibody test. Both products have been granted Class 4 Medical Device Licenses, the highest regulatory classification for medical...

Read more

Todd Eller Unveils Effective Strategies to Enhance Social Skills in Individuals with Autism

February 25, 2025 4:30 PM

Dr. Todd Eller, a leading educator, researcher, and advocate for autism intervention, has introduced a comprehensive framework designed to help individuals with Autism Spectrum Disorder (ASD) develop essential social skills. Drawing from nearly two decades of experience in behavioral intervention, Dr. Eller's approach focuses on practical, evidence-based techniques that empower individuals with autism to communicate effectively, build meaningful...

Read more

NHI Announces First Quarter 2025 Dividend

February 25, 2025 4:15 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to stockholders of record as of March 31, 2025.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and...

Read more

NHI Issues Investor Update

February 25, 2025 4:15 PM

National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical...

Read more

NHI Announces Fourth Quarter 2024 Results

February 25, 2025 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended December 31, 2024 was $0.95 compared to $0.74 during the same period in the prior year. Net income attributable to common stockholders per diluted common share was $3.13 for both the...

Read more

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

February 25, 2025 4:01 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida,...

Read more

CGFNS International to Change Its Name to TruMerit

February 25, 2025 3:00 PM

As it expands its mission to support healthcare workforce development on a global scale, CGFNS International announced today it will change its name to TruMerit™, a decision approved by the CGFNS Board of Trustees in fall of 2024.The initiative signifies a new journey for CGFNS, an acronym for Commission on Graduates of Foreign Nursing Schools, which for nearly a half-century has supported the career mobility of nurses and other healthcare...

Read more

Behind the Numbers: Working To Tackle Breast Cancer in Ghana

February 25, 2025 2:05 PM

Breast cancer remains a significant health challenge globally with approximately 2.3M new cases in 20221. While breast cancer deaths continue to fall in many countries worldwide, in others the situation is very different. In this article we meet some of the inspiring people who are working to change this situation.Breast cancer is still the world's most prevalent cancer, but survival rates have greatly improved since the 1980s in countries that...

Read more

Innovaccer Earns Top Ranking in 2025 Black Book Survey Under New Rigorous AI-Specific KPIs for Population Health Management

February 25, 2025 10:00 AM

Innovaccer has been named the top AI-driven population health management (PHM) vendor in Black Book Research's 2025 independent survey, earning the highest ranking under new, more stringent AI-specific Key Performance Indicators (KPIs).Across multiple categories of HIT competitive intelligence, Black Book Research's rankings include 18 newly developed AI-focused KPIs designed to provide a deeper, more comprehensive evaluation of how vendors...

Read more

CORRECTION FROM SOURCE: Royal Biologics Announces Strategic Partnership With Coldplasmatech GmbH

February 25, 2025 10:00 AM

Royal Wound-X, a division of Royal Biologics committed to pioneering advanced wound care solutions, and Coldplasmatech GmbH, an innovator in medical cold plasma technology, today announce their strategic partnership aimed at transforming the treatment landscape for complex and chronic wounds worldwide.Chronic and acute wounds, including those complicated by multi-resistant infections, affect nearly one billion people globally and represent an...

Read more

Incredible KLAS Outcomes! AGFA HealthCare Achieves Triple KLAS Wins and Excels in PACS Radiology & Cardiology Ratings in USA!

February 25, 2025 9:01 AM

AGFA HealthCare proudly celebrates multiple KLAS distinctions, securing two #1 Best in KLAS awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product award. Additionally, AGFA HealthCare earned exceptional ratings in PACS Radiology and Cardiology reviews. These prestigious recognitions affirm AGFA HealthCare's unwavering commitment to innovation and customer success.Outstanding Performance in PACS RadiologyBeyond the...

Read more

Black Book Research Unveils 2025’s Top-Rated Population Health & Value-Based Care Vendors: AI, Interoperability, and ROI Take Center Stage

February 25, 2025 9:00 AM

Black Book Research, a leading independent healthcare research firm, has released its highly anticipated 2025 rankings of top-rated vendors in population health and value-based care solutions. Based on direct client feedback from 2,230 healthcare professionals across hospitals, physician organizations, health plans, and accountable care organizations (ACOs), the report identifies the most trusted and effective technology providers shaping the...

Read more

viemaa Revolutionizes Hair Care with a Patented Biomimetic Cuticle Technology

February 25, 2025 9:00 AM

viemaa, a woman and minority-owned beauty brand, is proud to announce the launch of its ground-breaking bond building hair care collection featuring a patented breakthrough biomimetic cuticle technology.The viemaa brand succinctly describes its revolutionary approach to hair care as SCIENCE MEETS STYLETM.The patented technology coupled with hydrolyzed pea protein, which is similar to the amino acids commonly found in hair tackles the root cause...

Read more

Alter Behavioral Health Opens New Residential Mental Health Facility in San Diego

February 25, 2025 9:00 AM

Alter Behavioral Health has opened a new Residential Mental Health Facility in San Diego. This center helps people struggling with mental health problems. It provides care that is kind and works well, instead of regular hospital visits. The facility is open 24 hours a day, seven days a week, and feels like a home. It aims to help people who have thoughts of hurting themselves, suicide or severe mental distress."This opening is an important step...

Read more

StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use

February 25, 2025 9:00 AM

StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is thrilled to announce a new partnership with ADM Tronics Unlimited, Inc., (ADMT) a leader in electronic medical device engineering. This collaboration aims to redesign StimCell's proprietary eBalance® microcurrent device, transforming it into a compact, affordable consumer unit...

Read more

Royal Biologics Announces Strategic Partnership With Coldplasmatech GmbH

February 25, 2025 9:00 AM

Royal Wound-X, a division of Royal Biologics committed to pioneering advanced wound care solutions, and Coldplasmatech GmbH, an innovator in medical cold plasma technology, today announce their strategic partnership aimed at transforming the treatment landscape for complex and chronic wounds worldwide.Chronic and acute wounds, including those complicated by multi-resistant infections, affect nearly one billion people globally and represent an...

Read more

Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 25 February 2025

February 25, 2025 8:55 AM

Ascelia Pharma (STO:ACE) Today, on 25 February 2025, an extraordinary general meeting was held in Ascelia Pharma AB. A summary of the adopted resolutions follows below.Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrantsThe general meeting resolved in accordance with the proposal from the board of directors to implement an employee option program for all employees of the company. The...

Read more

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis

February 25, 2025 7:58 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced the Australian Patent Office has accepted its patent application for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Australian Patent Application No....

Read more